Skip to content

Sex Differences in the Risk of Cardiovascular Diseases Associated With Diabetes

Sex Differences in the Risk of Cardiovascular Diseases Associated With Diabetes: an Examination of Variation in Health Service Delivery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02542774
Enrollment
80000
Registered
2015-09-07
Start date
2015-08-31
Completion date
2016-11-30
Last updated
2015-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Diabetes mellitus, Stroke, Myocardial infarction, Stable angina pectoris, Heart failure, Quality of care

Brief summary

To evaluate the risk of cardiovascular events associated with medication use for controlling blood glucose, blood pressure and cholesterol levels in men and women with diabetes treated in primary care

Detailed description

The management and treatment of adult diabetes is far from optimal. The most recent report from the National Diabetes Audit showed that only one in three people with diabetes are achieving recommended standards for controlling blood glucose, blood pressure and cholesterol levels; and only three in five received basic care processes to reduce their risk of diabetes-related complications such as blindness, amputation and kidney disease. Women did 15% worse than men, which may explain some of the reported higher excess risk of coronary heart disease and stroke, consequent to diabetes in women than men. More efficient and equitable care in people with diabetes could lead to substantial cost savings, and would improve the lives of women and men currently living with diabetes. The objective of this research isto evaluate the risk of cardiovascular events associated with medication use for controlling blood glucose, blood pressure and cholesterol levels in men and women with diabetes treated in primary care.

Interventions

OTHERNo intervention is given.

This study is based on the analysis of linked electronic health records (CALIBER dataset)

Sponsors

University College, London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients with diabetes at or before study entry, and participants who develop new-onset diabetes during follow-up. * Age ≥ 18 years * Data collected in the period 1997-2010 * Minimum time since registration of 1 year * Minimum of 1 year of up to standard data (CPRD quality standard)

Exclusion criteria

• None

Design outcomes

Primary

MeasureTime frameDescription
First occurrence of cardiovascular disease10 yearsFirst recorded diagnosis of cardiovascular disease during follow-up: stable angina, unstable angina, myocardial infarction, unheralded coronary death, heart failure, transient ischaemic attack, ischaemic stroke, subarachnoid haemorrhage, intracerebral haemorrhage, peripheral arterial disease, abdominal aortic aneurysm, ventricular arrhythmia, cardiac arrest, or sudden cardiac death

Secondary

MeasureTime frameDescription
Cardiovascular mortality10 yearsComposite endpoint of cardiovascular mortality
All cause mortality10 yearsComposite endpoint of all cause mortality

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026